These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36176729)

  • 21. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway.
    Zhao M; Wang Y; Liu Y; Zhang W; Liu Y; Yang X; Cao Y; Wang S
    Cancer Biol Ther; 2019; 20(12):1430-1442. PubMed ID: 31441380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling.
    Yu J; Xia X; Dong Y; Gong Z; Li G; Chen GG; Lai PBS
    Theranostics; 2021; 11(5):2123-2136. PubMed ID: 33500715
    [No Abstract]   [Full Text] [Related]  

  • 24. MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.
    Liu Y; Tan J; Ou S; Chen J; Chen L
    Invest New Drugs; 2020 Feb; 38(1):60-69. PubMed ID: 30929159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of ERβ Participates in the Progression of Liver Cancer via Inhibiting the Notch Signaling Pathway [Retraction].
    Onco Targets Ther; 2020; 13():6849. PubMed ID: 32764973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
    Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway [Retraction].
    Onco Targets Ther; 2022; 15():83-84. PubMed ID: 35087277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRT6 Overexpression Induces Apoptosis of Nasopharyngeal Carcinoma by Inhibiting NF-κB Signaling [Retraction].
    Onco Targets Ther; 2024; 17():161-162. PubMed ID: 38426082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
    Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma.
    Wang H; Rao B; Lou J; Li J; Liu Z; Li A; Cui G; Ren Z; Yu Z
    Front Cell Dev Biol; 2020; 8():55. PubMed ID: 32117981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2022; 15():85-86. PubMed ID: 35087278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-Induced Aquaporin-3 Changes Hepatocellular Carcinoma Cell Sensitivity to Sorafenib by Activating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():9027-9028. PubMed ID: 34916846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
    Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():177-178. PubMed ID: 36960309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction Note to: Correlations between chromobox homolog 8 and key factors of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhu X; Luo W; Bei C; Kong J; Zhang S; Fu Y; Li D; Tan S
    Cancer Cell Int; 2020; 20():486. PubMed ID: 33041667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.